TNF-β, the closest structural homolog to TNF-α, was identified around 35 years ago [14,15] and has recently come to attention as it may stimulate NF-κB activation in cancer cells with a similar potency to TNF-α, thereby up-regulating proliferation, invasion and malignancy of cancer cells [16,17,18]. Here, NFKB1 is linked to cancer.